https://www.selleckchem.com/
One patient required a second instillation of FG achieving a clinical response. No adverse events related to the procedure were recorded, however one patient died for causes not related to the procedure. Median Interstitial Cystitis Symptoms Index was 13.0 (IQR 11.0-15. pre-operatively and 4.0 (IQR 2.0-5. post-operatively. Our study showed that, even in hematological patients, autologous FG instillation maybe a safe, repeatable and effective treatment modality in patients with refractory HC. Our study showed that, even in hematological patients, autolog
Like
Comment
Share
